◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

ENVERIC BIOSCIENCES, INC.

CIK: 890821 SIC: 2834
-
Revenue
$-9.73M
Net Income
-
Gross Margin
-
Op. Margin
$-14.34M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 10 annual reports available (2011 - 2024)
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
+ Total Revenue - - - - - $43.00M
Revenue Growth % nan% nan% nan% nan% nan% nan%
Cost of Revenue - - - - - $34.01M
+ Gross Profit - - - - - $8.98M
Gross Margin % nan% nan% nan% nan% nan% 20.9%
Operating Expenses - - - - - $16.13M
Research & Development $3.51M $2.84M $7.25M $4.79M $174.08K -
Selling General & Admin - - - $20.50M $5.44M $10.79M
+ Operating Income $-9.75M $-9.63M $-16.45M $-64.62M $-5.62M $-7.15M
Operating Margin % nan% nan% nan% nan% nan% -16.6%
Interest Expense - - - $10.32K $445.25K $729.90K
Other Income/Expense - $66.21K $-814.38K $8.19M $1.25M $-3.40M
Income Before Tax $-9.73M $-9.57M $-17.26M $-56.43M $-6.86M $-10.55M
Income Tax Expense - $8.93K $28.91K $-7.45M - $6.35M
+ Net Income $-9.73M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M
Net Margin % nan% nan% nan% nan% nan% -39.3%
Basic EPS -31.09 -19.04 -8.09 nan nan -0.82
Diluted EPS -31.09 -19.04 -8.09 nan nan -0.82
Basic Shares Outstanding 313K 503K 2.2M - 5.8M 23.8M
Diluted Shares Outstanding 313K 503K 2.2M - - 23.8M
Breakdown FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
Cash & Cash Equivalents $2.24M $2.29M $17.36M $1.58M $1.37M
Accounts Receivable - - - - $7.87M
Other Current Assets $493.56K $1.29M $380.84K $700.71K $818.60K
Total Current Assets $2.73M $3.58M $17.74M $2.28M $10.06M
Property Plant & Equipment $305.78K $507.38K $294.43K - $58.89K
Goodwill - - $1.59M - $13.73M
Intangible Assets $42.18K $210.93K $6.92M $1.82M $5.78M
Total Assets $3.08M $4.30M $26.72M $4.10M $29.64M
Accounts Payable $521.75K $1.22M - - $4.38M
Accrued Liabilities $732.01K $1.08M $1.29M - -
Other Current Liabilities - $23.61K - - -
Total Current Liabilities $1.49M $2.34M $2.08M $681.25K $14.69M
Long-term Debt - - - - -
Total Liabilities - - $4.41M $681.25K $18.88M
Common Stock $6.78K $27.39K $325.79K $100.95K $423.29K
Retained Earnings $-106.07M $-96.50M $-60.74M $-11.76M $-34.48M
Total Stockholders Equity $1.59M $1.96M $22.31M $3.42M $-65.45K
Total Liabilities & Equity $3.08M $4.30M $26.72M $4.10M $29.64M
Breakdown TTM
(Sep 30, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2018
(Dec 31, 2018)
Net Income $-11.92M $-9.57M $-17.29M $-48.98M $-6.86M $-16.90M
Depreciation & Amortization $243.86K $337.49K $343.98K $656.64K $120.87K $2.90M
Stock-based Compensation $1.65M $1.56M $2.15M - $1.98M -
Change in Receivables - - - - - $-967.03K
Operating Cash Flow $-14.34M $-7.73M $-14.09M $-11.46M $-3.89M $-2.57M
Capital Expenditure - - $5.18K - - -
Acquisitions - - - - - $3.65M
Investing Cash Flow - - $11.67K $2.19M $-44.14K $-3.64M
Stock Issued - $2.29M - $21.61M $488.00K $6.33M
Financing Cash Flow $17.70M $7.67M $-1.34M $24.90M $5.53M $2.69M
Net Change in Cash $3.31M $-46.95K $-15.44M $15.78M $1.53M $-3.51M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Research & Development $402.42K - $2.41M -
Operating Income $-1.87M - $-6.58M -
Interest Expense - - - -
Other Income/Expense - - $2.56K -
Income Before Tax $-1.87M - $-6.58M -
Income Tax Expense - - - -
Net Income $-1.87M $-1.88M $-6.58M -
Basic EPS -10.81 - -35.74 -
Diluted EPS -10.81 - -35.74 -
Basic Shares Outstanding $313.24K - $226.40K -
Diluted Shares Outstanding $313.24K - $226.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.76M $2.24M
Other Current Assets $407.95K $493.56K
Total Current Assets $4.17M $2.73M
Property Plant & Equipment $196.52K $305.78K
Intangible Assets - $42.18K
Total Assets $4.36M $3.08M
Accounts Payable $683.71K $521.75K
Other Current Liabilities - $232.89K
Total Current Liabilities $905.88K $1.49M
Common Stock $5.18K $565.00
Retained Earnings $-112.65M $-106.07M
Total Stockholders Equity $3.46M $1.59M
Total Liabilities & Equity $4.36M $3.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.87M $-1.88M $-6.58M -
Depreciation & Amortization $40.37K - $161.37K -
Stock-based Compensation - - $587.09K -
Operating Cash Flow - - $-6.36M -
Stock Issued - - - -
Financing Cash Flow - - $7.89M -
Net Change in Cash - - $1.52M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...